Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
10.65
-0.30 (-2.74%)
Mar 6, 2026, 9:31 AM EST - Market open
Korro Bio Employees
Korro Bio had 104 employees as of December 31, 2024. The number of employees increased by 2 or 1.96% compared to the previous year.
Employees
104
Change (1Y)
2
Growth (1Y)
1.96%
Revenue / Employee
$84,724
Profits / Employee
-$1,016,287
Market Cap
100.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104 | 2 | 1.96% |
| Dec 31, 2023 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 316 |
| Seer, Inc. | 134 |
| Fortress Biotech | 101 |
| Precision BioSciences | 67 |
| Biomea Fusion | 42 |
| Cassava Sciences | 30 |
| Gain Therapeutics | 25 |
| TuHURA Biosciences | 19 |
KRRO News
- 8 days ago - Korro to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Korro Bio, Inc. (KRRO) Analyst/Investor Day Transcript - Seeking Alpha
- 6 weeks ago - Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Korro to Host Virtual Analyst Day on January 27, 2026 - GlobeNewsWire
- 2 months ago - Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Korro Bio Early Trial Results Fall Short; Stock Hits New Low - Benzinga
- 4 months ago - This biotech is halting its work with Novo Nordisk and laying off more people - Market Watch
- 4 months ago - Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs - GlobeNewsWire